Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2013

Open Access 01-12-2013 | Research

RETRACTED ARTICLE: Changes in the electron paramagnetic resonance spectra of albumin-associated spin-labeled stearic acid as a diagnostic parameter of colorectal cancer

Authors: Zhongchao Liu, Wenyi Zhang, Saijun Fan, Liang Wang, Ling Jiao

Published in: World Journal of Surgical Oncology | Issue 1/2013

Login to get access

Abstract

Background

With more than 940,000 new colorectal cancer cases worldwide each year, there is no better way for colorectal cancer routine screening. The aim of this study was to investigate whether the fatty acid binding to albumin is detectably and significantly altered in colorectal cancer patients when compared with healthy people, in order to find a better way for colorectal cancer diagnosis.

Methods

One hundred and forty-one patients operatively treated for colorectal cancer were included in the examination, and 180 healthy people were also enrolled as controls. Commercial 16-doxyl stearic acid was used as spin probe. Serum albumin was analyzed by electron paramagnetic resonance (EPR) with spin probe. Discriminant analysis was carried out using the measured EPR spectra by SPSS 20.0.

Results

Of the original grouped cases, 89.4% were correctly classified. Of the cross-validated grouped cases, 86.9% were correctly classified. Using Fisher linear discriminant analysis we were able to develop a mathematical model allowing for identification of colorectal cancer patients based on five values (both relative intensity and peak width) which are obtained from the EPR spectrum.

Conclusions

Cancer-associated alterations to albumin can be assessed by spin-label EPR. The potential applications for this diagnostic technique are significant and represent a cost-effective means for screening patients with cancer. Spin probe for diagnosis of colorectal cancer might be a useful tool and further studies should take place in order to investigate all stages of colorectal cancer patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010, 46 (4): 765-781. 10.1016/j.ejca.2009.12.014.CrossRefPubMed Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010, 46 (4): 765-781. 10.1016/j.ejca.2009.12.014.CrossRefPubMed
2.
go back to reference Chalya PL, McHembe MD, Mabula JB, Rambau PF, Jaka H, Koy M, Mkongo E, Masalu N: Clinic pathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience. World J Surg Oncol. 2013, 11 (1): 88-97. 10.1186/1477-7819-11-88.CrossRefPubMedPubMedCentral Chalya PL, McHembe MD, Mabula JB, Rambau PF, Jaka H, Koy M, Mkongo E, Masalu N: Clinic pathological patterns and challenges of management of colorectal cancer in a resource-limited setting: a Tanzanian experience. World J Surg Oncol. 2013, 11 (1): 88-97. 10.1186/1477-7819-11-88.CrossRefPubMedPubMedCentral
3.
go back to reference Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O: Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007, 43 (9): 1348-1360. 10.1016/j.ejca.2007.03.021.CrossRefPubMed Duffy MJ, van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O: Tumor markers in colorectal cancer: European Group on Tumor Markers (EGTM) guidelines for clinical use. Eur J Cancer. 2007, 43 (9): 1348-1360. 10.1016/j.ejca.2007.03.021.CrossRefPubMed
4.
go back to reference Peters T: All About Albumin: Biochemistry, Genetics, and Medical Applications. 1995, California: Academic Press Peters T: All About Albumin: Biochemistry, Genetics, and Medical Applications. 1995, California: Academic Press
5.
go back to reference Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, Markussen J: Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J. 1995, 312 (Pt 3): 725-731.CrossRefPubMedPubMedCentral Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, Markussen J: Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. Biochem J. 1995, 312 (Pt 3): 725-731.CrossRefPubMedPubMedCentral
6.
go back to reference Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998, 5: 827-835. 10.1038/1869.CrossRefPubMed Curry S, Mandelkow H, Brick P, Franks N: Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Biol. 1998, 5: 827-835. 10.1038/1869.CrossRefPubMed
7.
go back to reference Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF, Liotta LA: Biomarker amplification by serum carrier protein binding. Dis Markers. 2003, 19 (1): 1-10. 10.1155/2003/104879.CrossRefPubMed Mehta AI, Ross S, Lowenthal MS, Fusaro V, Fishman DA, Petricoin EF, Liotta LA: Biomarker amplification by serum carrier protein binding. Dis Markers. 2003, 19 (1): 1-10. 10.1155/2003/104879.CrossRefPubMed
8.
go back to reference Shenkar MG, Rananavare B, Freed JH: ESR studies of stearic acid binding to bovine serum albumin. Biochim Biophys Acta. 1990, 1036 (3): 228-236. 10.1016/0304-4165(90)90039-Y.CrossRef Shenkar MG, Rananavare B, Freed JH: ESR studies of stearic acid binding to bovine serum albumin. Biochim Biophys Acta. 1990, 1036 (3): 228-236. 10.1016/0304-4165(90)90039-Y.CrossRef
9.
go back to reference Bhattacharya AA, Grüne T, Curry S: Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol. 2000, 303 (5): 721-732. 10.1006/jmbi.2000.4158.CrossRefPubMed Bhattacharya AA, Grüne T, Curry S: Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J Mol Biol. 2000, 303 (5): 721-732. 10.1006/jmbi.2000.4158.CrossRefPubMed
10.
go back to reference Seidel P, Gurachevsky A, Muravsky V, Schnurr K, Seibt G, Matthes G: Recognition of malignant processes with neural nets from ESR spectra of serum albumin. Z Med Phys. 2005, 15 (4): 265-272.CrossRefPubMed Seidel P, Gurachevsky A, Muravsky V, Schnurr K, Seibt G, Matthes G: Recognition of malignant processes with neural nets from ESR spectra of serum albumin. Z Med Phys. 2005, 15 (4): 265-272.CrossRefPubMed
11.
go back to reference Kazmierczak SC, Gurachevsky A, Matthes G, Muravsky V: Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. Clin Chem. 2006, 52 (11): 2129-2134. 10.1373/clinchem.2006.073148.CrossRefPubMed Kazmierczak SC, Gurachevsky A, Matthes G, Muravsky V: Electron spin resonance spectroscopy of serum albumin: a novel new test for cancer diagnosis and monitoring. Clin Chem. 2006, 52 (11): 2129-2134. 10.1373/clinchem.2006.073148.CrossRefPubMed
12.
go back to reference Gammerman A, Nouretdinov I, Burford B, Chervonenkis A, Vovk V, Luo Z: Clinical mass spectrometry proteomic diagnosis by conformal predictors. Stat Appl Genet Mol Biol. 2008, 7 (2): Article13-PubMed Gammerman A, Nouretdinov I, Burford B, Chervonenkis A, Vovk V, Luo Z: Clinical mass spectrometry proteomic diagnosis by conformal predictors. Stat Appl Genet Mol Biol. 2008, 7 (2): Article13-PubMed
13.
go back to reference de Noo ME, Mertens BJ, Ozalp A, Bladergroen MR, van der Werff MP, van de Velde CJ, Deelder AM, Tollenaar RA: Detection of colorectal cancer using MALDI-TOF serum protein profiling. Eur J Cancer. 2006, 42 (8): 1068-1076. 10.1016/j.ejca.2005.12.023.CrossRefPubMed de Noo ME, Mertens BJ, Ozalp A, Bladergroen MR, van der Werff MP, van de Velde CJ, Deelder AM, Tollenaar RA: Detection of colorectal cancer using MALDI-TOF serum protein profiling. Eur J Cancer. 2006, 42 (8): 1068-1076. 10.1016/j.ejca.2005.12.023.CrossRefPubMed
14.
go back to reference Kalnina I, Kurjane N, Kirilova E, Klimkane L, Kirilov G, Zvagule T: Correlation of altered blood albumin characteristics and lymphocyte populations to tumor stage in gastrointestinal cancer patients. Cancer Biomark. 2010, 7 (2): 91-99.PubMed Kalnina I, Kurjane N, Kirilova E, Klimkane L, Kirilov G, Zvagule T: Correlation of altered blood albumin characteristics and lymphocyte populations to tumor stage in gastrointestinal cancer patients. Cancer Biomark. 2010, 7 (2): 91-99.PubMed
15.
go back to reference Berezin MY, Lee H, Akers W, Nikiforovich G, Achilefu S: Ratiometric analysis of fluorescence lifetime for probing binding sites in albumin with near‒infrared fluorescent molecular probes. Photochem Photobiol. 2007, 83 (6): 1371-1378. 10.1111/j.1751-1097.2007.00173.x.CrossRefPubMed Berezin MY, Lee H, Akers W, Nikiforovich G, Achilefu S: Ratiometric analysis of fluorescence lifetime for probing binding sites in albumin with near‒infrared fluorescent molecular probes. Photochem Photobiol. 2007, 83 (6): 1371-1378. 10.1111/j.1751-1097.2007.00173.x.CrossRefPubMed
16.
go back to reference Gurachevsky A, Muravsky V, Matthes G: Changes in serum albumin measured by electron spin resonance: in vitro diagnostic EPR test. Proc Int Soc Magn Reson Med. 2007, 15: 1323- Gurachevsky A, Muravsky V, Matthes G: Changes in serum albumin measured by electron spin resonance: in vitro diagnostic EPR test. Proc Int Soc Magn Reson Med. 2007, 15: 1323-
17.
go back to reference Rhodes CJ: Electron spin resonance. Part one: a diagnostic method in the biomedical sciences. Sci Prog. 2011, 94 (1): 16-96. 10.3184/003685011X12982218769939.CrossRefPubMed Rhodes CJ: Electron spin resonance. Part one: a diagnostic method in the biomedical sciences. Sci Prog. 2011, 94 (1): 16-96. 10.3184/003685011X12982218769939.CrossRefPubMed
18.
go back to reference Gurachevsky A, Kazmierczak SC, Jörres A, Muravsky V: Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis. Clin Chem Lab Med. 2008, 46 (9): 1203-1210.CrossRefPubMed Gurachevsky A, Kazmierczak SC, Jörres A, Muravsky V: Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis. Clin Chem Lab Med. 2008, 46 (9): 1203-1210.CrossRefPubMed
19.
go back to reference Gelos M, Hinderberger D, Welsing E, Belting J, Schnurr K, Mann B: Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis. 2010, 25 (1): 119-127. 10.1007/s00384-009-0777-0.CrossRefPubMed Gelos M, Hinderberger D, Welsing E, Belting J, Schnurr K, Mann B: Analysis of albumin fatty acid binding capacity in patients with benign and malignant colorectal diseases using electron spin resonance (ESR) spectroscopy. Int J Colorectal Dis. 2010, 25 (1): 119-127. 10.1007/s00384-009-0777-0.CrossRefPubMed
Metadata
Title
RETRACTED ARTICLE: Changes in the electron paramagnetic resonance spectra of albumin-associated spin-labeled stearic acid as a diagnostic parameter of colorectal cancer
Authors
Zhongchao Liu
Wenyi Zhang
Saijun Fan
Liang Wang
Ling Jiao
Publication date
01-12-2013
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2013
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-11-223

Other articles of this Issue 1/2013

World Journal of Surgical Oncology 1/2013 Go to the issue